Prognostic Value and Determinants of High-Sensitivity Cardiac Troponin T in Patients With a Systemic Right Ventricle: Insights From the SERVE Trial

Francisco Javier Ruperti-Repilado , MD; Fabian Tran, MD; Philip Haaf , MD; Pedro Lopez-Ayala Matthias Greutmann , MD; Markus Schwerzmann , MD; Judith Bouchardy , MD; Harald Gabriel Dominik Stambach, MD; Tobias Rutz , MD; Juerg Schwitter , MD; Kerstin Wustmann , MD; Michael Freese, MSc; Christian Mueller , MD; Daniel Tobler , MD

J Am Heart Assoc. 2024;13:e034776. DOI: 10.1161/JAHA.123.034776

Effect of phosphodiesterase-5 inhibition on SystEmic Right VEntricular size and function – A multicentre, double-blind, randomized, placebo-controlled trial – SERVE

Matthias Greutmann, Daniel Tobler, Reto Engel, Dik Heg, Christian Mueller, André Frenk, Harald Gabriel, Tobias Rutz, Ronny R. Buechel, Matthias Willhelm, Lukas Trachsel, Michael Freese, Francisco Javier Ruperti-Repilado, Emanuela Valsangiacomo Buechel, Dietrich Beitzke, Philip Haaf, Kerstin Wustmann, Fabienne Schwitz, Mathias Possner, Juerg Schwitter, Judith Bouchardy, and Markus Schwerzmann, on behalf of the SERVE Investigators
European Journal of Heart Failure (2023) doi:10.1002/ejhf.2924